Health and Wellness

Loss Of MRNA, Bird Flu Vaccines Threatens Our Biosecurity

Amid growing concerns over the spread of bird flu, the Department of Health and Human Services made a surprising announcement today. They have decided to cancel a $760 million contract

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

New Ebola outbreak is confirmed in a remote Congo province

KINSHASA, Congo — On Friday, Africa's leading public health organization announced a new Ebola outbreak in the remote Ituri province

Second Trump Administration’s Pivot On Vaping Leads To Resignations

FDA Commissioner Marty Makary said he resigned in protest against the Trump administration's push to allow tobacco companies to begin

Study: PSA tests likely reduce risk of death from prostate cancer

A recent review published on Thursday by a prominent international science research organization suggests that prostate-specific antigen (PSA) blood testing

How Climate Change Is Helping Tropical Diseases Gain A Foothold In The U.S.

Female Aedes aegypti mosquito, a carrier of the Dengue fever, feeding on the human skin, 2005. Image courtesy Centers for

Hantavirus, FDA, alcohol addiction, Medicare: Morning Rounds

Theresa is the lead Morning Rounds writer, and her stories focus on gender-affirming care, reproductive health, and mental health. You

Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery

Demis Hassabis, CEO of Isomorphic and Google DeepMind© 2025 Bloomberg Finance LPFounded as an Alphabet entity in 2021, Isomorphic holds

CDC defends hantavirus response: ‘Engaged at every step’

On Wednesday, two doctors from the Centers for Disease Control and Prevention stated that the hantavirus outbreak poses a low

Teaching Your Body To Make Designer Antibodies

Teaching the body to manufacture “designer” antibodies from a tiny pool of edited stem cells could turn today’s short‑lived antibody